Roche reported its H1 results, with underlying execution described as solid and core profit growth outpacing sales growth despite foreign-exchange pressure.
An analyst downgrade was issued citing a now-balanced risk-reward profile for the stock.
Roche H1 Results Show Core Profit Growth Outpacing Sales; Rating Downgraded
Roche reported strong H1 execution with core profit growth exceeding sales growth amid FX pressure, prompting a rating downgrade as risk-reward becomes more balanced.
PA
Priya Anand · Equities & Earnings Desk · 17 Sept 2026 · 08:51 · 1 min read
This article was produced with AI assistance and edited by a Finance Review Daily journalist.
ADVERTISEMENT
PA
Written by
Priya Anand
Equities & Earnings Desk
Priya covers listed equities and corporate earnings, reading quarterly results and guidance for what they signal about sector health and forward valuations.
More from Priya Anand →
